183 related articles for article (PubMed ID: 31608533)
1. Primary malignant melanoma of the uterine cervix or vagina which were successfully treated with nivolumab.
Anko M; Nakamura M; Kobayashi Y; Tsuji K; Nakada S; Nakamura Y; Funakoshi T; Banno K; Aoki D
J Obstet Gynaecol Res; 2020 Jan; 46(1):190-195. PubMed ID: 31608533
[TBL] [Abstract][Full Text] [Related]
2. Primary vaginal malignant melanoma: A rare case report of successful treatment with nivolumab.
Guo N; Zhang J
Medicine (Baltimore); 2021 Apr; 100(17):e25691. PubMed ID: 33907144
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.
Inoue K; Tsubamoto H; Isono-Nakata R; Sakata K; Nakagomi N
BMC Cancer; 2018 Jun; 18(1):630. PubMed ID: 29866134
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
Naumann RW; Hollebecque A; Meyer T; Devlin MJ; Oaknin A; Kerger J; López-Picazo JM; Machiels JP; Delord JP; Evans TRJ; Boni V; Calvo E; Topalian SL; Chen T; Soumaoro I; Li B; Gu J; Zwirtes R; Moore KN
J Clin Oncol; 2019 Nov; 37(31):2825-2834. PubMed ID: 31487218
[TBL] [Abstract][Full Text] [Related]
5. Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?
Quéreux G; Wylomanski S; Bouquin R; Saint-Jean M; Peuvrel L; Knol AC; Hanf M; Dréno B
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e39-e40. PubMed ID: 28750150
[No Abstract] [Full Text] [Related]
6. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
7. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report.
Rochefort P; Roussel J; de la Fouchardière A; Sarabi M; Desseigne F; Guibert P; Cattey-Javouhey A; Mastier C; Neidhardt-Berard EM; de la Fouchardière C
Immunotherapy; 2018 Aug; 10(10):831-835. PubMed ID: 30073896
[TBL] [Abstract][Full Text] [Related]
8. Primary malignant melanoma of the cervix: a rare disease.
Julião I; Carvalho SD; Patricio V; Raimundo A
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432169
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of the clinical value of colposcopy in diagnosing vagina invasion in cervical cancer].
Zhu YL; Zhang WH; Liu BB; Zhang P; Zhang J; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):322-326. PubMed ID: 32464720
[No Abstract] [Full Text] [Related]
10. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
[TBL] [Abstract][Full Text] [Related]
11. [Primary malignant melanoma of vagina].
Daix M; Dillies P; Gueuning A; Watkins-Masters L; Gielen F
Rev Med Liege; 2018 Jul; 73(7-8):413-418. PubMed ID: 30113785
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
[TBL] [Abstract][Full Text] [Related]
13. A Case of Malignant Melanoma of the Uterine Cervix with Disseminated Metastases throughout the Vaginal Wall.
Noguchi T; Ota N; Mabuchi Y; Yagi S; Minami S; Okuhira H; Yamamoto Y; Nakamura Y; Ino K
Case Rep Obstet Gynecol; 2017; 2017():5656340. PubMed ID: 28197351
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Kreft S; Gesierich A; Eigentler T; Franklin C; Valpione S; Ugurel S; Utikal J; Haferkamp S; Blank C; Larkin J; Garbe C; Schadendorf D; Lorigan P; Schilling B
Eur J Cancer; 2019 Jul; 116():207-215. PubMed ID: 31212163
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
Tsubamoto H; Kanazawa R; Inoue K; Ito Y; Komori S; Maeda H; Hirota S
Int J Gynecol Cancer; 2012 Jul; 22(6):1057-62. PubMed ID: 22683943
[TBL] [Abstract][Full Text] [Related]
16. Primary malignant melanoma of the cervix: report of a case.
Yücesoy G; Kus E; Cakiroglu Y; Muezzinoglu B; Yildiz K; Yucesoy I
Arch Gynecol Obstet; 2009 Apr; 279(4):573-5. PubMed ID: 18726108
[TBL] [Abstract][Full Text] [Related]
17. Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.
Paterniti TA; Dorr K; Ullah A; White J; Williams H; Ghamande S
Obstet Gynecol; 2021 Nov; 138(5):813-816. PubMed ID: 34619736
[TBL] [Abstract][Full Text] [Related]
18. Primary malignant melanoma of the vagina and cervix uteri: case report and literature review.
Chang SC; Chen CJ; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Oct; 50(4):341-6. PubMed ID: 1334796
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.
Miyashita A; Fukushima S; Tsukamoto H; Itai H; Miyamoto H; Nakahara S; Kubo Y; Kimura T; Kuriyama H; Ihn H
J Dermatol; 2019 Sep; 46(9):e339-e341. PubMed ID: 30908699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
